寻找最佳比例:全血与红细胞比例与出血性平民创伤患者结局的关联
该研究基于ACS-TQIP数据库2020-2021年数据,回顾性分析830例成人创伤患者(休克指数>1,入院4小时内接受至少5U浓缩红细胞和1U全血)。中位4小时全血和浓缩红细胞用量分别为2U和10U,中位全血:红细胞比值为0.2。全血:红细胞比值每增加0.1,24小时死亡风险降低(aOR 0.916,P=0.035),院内死亡风险降低(aOR 0.878,P<0.001)。约登指数确定0.25为降低24小时死亡率的最佳比值;高比值组(≥0.25)相比低比值组,24小时死亡风险(aOR 0.678,P=0.021)和院内死亡风险(aOR 0.618,P<0.001)均更低。作者认为,鉴于美国创伤中心全血可及,可每4U浓缩红细胞给予至少1U全血以改善生存。
要点
- 在830例出血性休克平民创伤患者中,全血:浓缩红细胞比值每增加0.1,24小时死亡风险降低(aOR 0.916,P=0.035),院内死亡风险降低(aOR 0.878,P<0.001)。
- 约登指数确定全血:浓缩红细胞比值0.25(每4U浓缩红细胞对应1U全血)为降低24小时死亡率的最佳比值。
- 高比值组(≥0.25)相比低比值组,24小时死亡风险更低(aOR 0.678,P=0.021),院内死亡风险更低(aOR 0.618,P<0.001)。
- 作者认为,鉴于美国创伤中心全血可及,可每4U浓缩红细胞给予至少1U全血以改善出血性平民创伤患者生存。
适用人群与场景
- 成人(≥18岁)创伤患者,休克指数(SI)>1,入院4小时内接受至少5U浓缩红细胞和至少1U全血。
- 数据来源为ACS-TQIP数据集2020-2021年,平民创伤人群。
诊断标准与关键阈值
- 纳入标准:成人(≥18岁)创伤患者,休克指数(SI)>1,入院4小时内接受至少5U浓缩红细胞和至少1U全血。
- 约登指数确定全血:浓缩红细胞比值0.25(每4U浓缩红细胞对应1U全血)为降低24小时死亡率的最佳比值。
处置流程与药物剂量
- 作者认为,鉴于美国创伤中心全血可及,可每4U浓缩红细胞给予至少1U全血以改善出血性平民创伤患者生存。
研究设计与关键结果
- 研究类型:基于ACS-TQIP数据集的2年(2020-2021)回顾性分析;样本量830例创伤患者,平均(SD)年龄38(16)岁。
- 中位[IQR] 4小时全血和浓缩红细胞需求量分别为2[2-4] U和10[7-15] U,中位全血:红细胞比值为0.2[0.1-0.3]。
- 全血:红细胞比值每增加0.1,24小时死亡风险降低(aOR 0.916,P=0.035),院内死亡风险降低(aOR 0.878,P<0.001)。
- 高比值组(≥0.25)相比低比值组,24小时死亡风险更低(aOR 0.678,P=0.021),院内死亡风险更低(aOR 0.618,P<0.001)。
证据类型、等级与局限
- 证据类型:回顾性分析(基于ACS-TQIP数据集)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,鉴于美国创伤中心全血可及,可每4U浓缩红细胞给予至少1U全血以改善出血性平民创伤患者生存。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Purpose: To evaluate the dose-dependent effect of whole blood (WB) on the outcomes of civilian trauma patients with hemorrhagic shock. Methods: We performed a 2-year (2020-2021) retrospective analysis of the ACS-TQIP dataset. Adult (≥18) trauma patients with a shock index (SI) >1 who received at least 5 units of PRBC and one unit of WB within the first 4 h of admission were included. Primary outcomes were 6-h, 24-h, and in-hospital mortality. Secondary outcomes were major complications and hospital and intensive care unit length of stay. Results: A total of 830 trauma patients with a mean (SD) age of 38 (16) were identified. The median [IQR] 4-h WB and PRBC requirements were 2 [2-4] U and 10 [7-15] U, respectively, with a median WB:RBC ratio of 0.2 [0.1-0.3]. Every 0.1 increase in WB:RBC ratio was associated with decreased odds of 24-h mortality (aOR: 0.916, P = 0.035) and in-hospital mortality (aOR: 0.878, P < 0.001). Youden's index identified 0.25 (1 U of WB for every 4 U of PRBC) as the optimal WB:PRBC ratio to reduce 24-h mortality. High ratio (≥0.25) group had lower adjusted odds of 24-h mortality (aOR: 0.678, P = 0.021) and in-hospital mortality (aOR: 0.618, P < 0.001) compared to the low ratio group. Conclusions: A higher WB:PRBC ratio was associated with improved early and late mortality in trauma patients with hemorrhagic shock. Given the availability of WB in trauma centers across the United States, at least one unit of WB for every 4 units of packed red blood cells may be administered to improve the survival of hemorrhaging civilian trauma patients.
参考来源
- Hosseinpour H, Stewart C, Hejazi O, et al. FINDING THE SWEET SPOT: THE ASSOCIATION BETWEEN WHOLE BLOOD TO RED BLOOD CELLS RATIO AND OUTCOMES OF HEMORRHAGING CIVILIAN TRAUMA PATIENTS. Shock. 2024. PMID: 38888586. doi:10.1097/SHK.0000000000002405
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。